Followers | 240 |
Posts | 12051 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Tuesday, April 21, 2015 1:33:58 PM
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE MKT: RVP) announced that on April 20, 2015, the Supreme Court of the United States denied the petition for a writ of certiorari by Becton, Dickinson and Company (“BD”) relating to its Rule 60(b) motion in the portion of Retractable’s case against BD addressing patent infringement claims.
The patent claims were severed from Retractable’s other claims against BD in 2008. The other portion of the case in which the District Court granted Retractable a final judgment for $352 million plus other relief is not directly affected by the recent Supreme Court ruling.
Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. Retractable's products are distributed by various specialty and general line distributors.
For more information on Retractable, visit our website at www.vanishpoint.com.
http://www.businesswire.com/news/home/20150421006314/en/Retractable-Technologies-Announces-U.S.-Supreme-Court-Decision#.VTZ0g4ktGUk
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent BDX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 05:54:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 05:53:43 PM
- BD Reports Second Quarter Fiscal 2024 Financial Results • PR Newswire (US) • 05/02/2024 10:30:00 AM
- BD Board Declares Dividend • PR Newswire (US) • 04/30/2024 08:15:00 PM
- BD to Present at Bank of America Securities Health Care Conference 2024 • PR Newswire (US) • 04/29/2024 08:15:00 PM
- BD Named a Best Employer for Excellence in Employee Well-Being • PR Newswire (US) • 04/09/2024 02:15:00 PM
- BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters • PR Newswire (US) • 04/05/2024 10:45:00 AM
- BD to Announce Financial Results for its Second Quarter of Fiscal 2024 • PR Newswire (US) • 04/04/2024 08:15:00 PM
- New Survey Reveals Patients Receive Too Many Needlesticks • PR Newswire (US) • 03/27/2024 10:50:00 AM
- BD Named Among Fortune's Most Innovative Companies • PR Newswire (US) • 03/26/2024 01:31:00 PM
- BD Increases Domestic Production to Support U.S. Health Care Need for Syringes • PR Newswire (US) • 03/21/2024 10:50:00 AM
- BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study • PR Newswire (US) • 03/18/2024 10:50:00 AM
- Zeus Names New Chief Executive Officer • PR Newswire (US) • 03/14/2024 05:00:00 PM
- New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities • PR Newswire (US) • 03/13/2024 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 05:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 05:14:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 05:13:27 PM
- BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease • PR Newswire (US) • 03/04/2024 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:54:50 AM
- Dave Hickey Announces Intent to Retire from BD • PR Newswire (US) • 02/27/2024 11:50:00 AM
- BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore • PR Newswire (US) • 02/21/2024 11:45:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:29:42 PM
- BD to Present at Investor Healthcare Conferences • PR Newswire (US) • 02/15/2024 09:15:00 PM
- BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease • PR Newswire (US) • 02/12/2024 09:43:00 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 02/09/2024 09:39:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM